Thomas DesRosier
2019
In 2019, Thomas DesRosier earned a total compensation of $977.3K as Chief Legal Officer, Executive Vice President, and Secretary at Seres Therapeutics, a 47% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $161,000 |
|---|---|
| Option Awards | $379,641 |
| Salary | $428,300 |
| Other | $8,400 |
| Total | $977,341 |
DesRosier received $428.3K in salary, accounting for 44% of the total pay in 2019.
DesRosier also received $161K in non-equity incentive plan, $379.6K in option awards and $8.4K in other compensation.
Rankings
In 2019, Thomas DesRosier's compensation ranked 9,371st out of 13,971 executives tracked by ExecPay. In other words, DesRosier earned more than 32.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,371 out of 13,971 | 33rd |
Division Manufacturing | 3,759 out of 5,695 | 34th |
Major group Chemicals And Allied Products | 1,427 out of 2,194 | 35th |
Industry group Drugs | 1,216 out of 1,880 | 35th |
Industry Pharmaceutical Preparations | 903 out of 1,392 | 35th |
Source: SEC filing on April 30, 2020.
DesRosier's colleagues
We found three more compensation records of executives who worked with Thomas DesRosier at Seres Therapeutics in 2019.